Insider trades

Joseph Shulman, Chief Officer of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 40 sales on the open market. Over the past 12 months that comes to a net sale of $3.1M. The latest trade was on 02/11.

Joseph Shulman

Chief Technical Officer
First filing
23/02/03
Trades
115 trades
Buys / sales
0 / 40
12-month net buying
−$3.1M
Last trade
02/11

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/10/3025/11/039,748 sh$115.24$1,123,359.52−53.4%
Open-market sale10b5-1 plan25/10/2825/10/302,815 sh$115.01$323,753.15−24.9%
RYTM
Open-market sale10b5-1 plan25/10/1625/10/2014,437 sh3 trades$112.03avg.$1,617,379.99−62.9%
Open-market sale10b5-1 plan25/09/0225/09/0416,781 sh$105.30$1,767,039.3−66.4%
Open-market sale10b5-1 plan25/08/2125/08/254,188 sh$100.07$419,093.16−33.0%
Open-market sale10b5-1 plan25/08/1125/08/133,984 sh$90.08$358,878.72−31.9%
RYTM
Open-market sale10b5-1 plan25/07/0925/07/117,969 sh2 trades$77.78avg.$619,831.04−48.4%
Open-market sale10b5-1 plan25/02/1925/02/191,228 sh$57.22$70,266.16−12.6%
RYTM
Open-market sale10b5-1 plan25/02/1225/02/14469 sh2 trades$56.40avg.$26,451.81−7.7%
RYTM
Open-market sale10b5-1 plan25/02/1125/02/11794 sh2 trades$57.51avg.$45,663.03−99.2%
Open-market sale25/02/0425/02/041,281 sh$59.43$76,129.83−32.5%
RYTM
Open-market sale10b5-1 plan24/11/1124/11/1313,281 sh3 trades$66.43avg.$882,319.77−100.0%
Open-market sale10b5-1 plan24/07/1624/07/1810,468 sh$53.00$554,804−99.7%
Open-market sale10b5-1 plan24/07/1224/07/165,313 sh$50.01$265,703.13−99.4%
RYTM
Open-market sale10b5-1 plan24/05/0924/05/133,984 sh2 trades$38.47avg.$153,265.92−99.3%
Open-market sale24/03/2124/03/2218,235 sh$40.34$735,599.9−99.8%
Open-market sale24/03/1924/03/1915,515 sh$39.22$608,498.3−45.9%
RYTM
Open-market sale10b5-1 plan24/02/13–24/02/1424/02/152,954 sh2 trades$50.00avg.$147,710.89−99.0%
RYTM
Open-market sale10b5-1 plan24/02/09–24/02/1324/02/1373,038 sh6 trades$50.39avg.$3,680,226.04−96.1%
Open-market sale24/02/0124/02/051,324 sh$45.06$59,659.44−33.6%